Revenue: As of FY2025 Q3, the actual value is USD 60.17 M.

EPS: As of FY2025 Q3, the actual value is USD -0.1.

EBIT: As of FY2025 Q3, the actual value is USD -1.707 M.

Segment Revenue

• Total revenue increased 13% year-over-year to $60.2 million, driven by an 18% increase in telehealth revenue to $47.3 million.

Operational Metrics

• Gross margin was 88%, down from 91% in the prior-year period, due to revenue mix. Telehealth gross margin, excluding WorkSimpli, was 86% compared to 89% in the year-ago period.
• GAAP net loss was $4.6 million or - $0.10 per share, compared to a net loss of $5.4 million or - $0.13 per share in the prior-year period.
• Adjusted EBITDA increased 20% to $5.1 million, with telehealth adjusted EBITDA rising 30% to $2.9 million.

Cash Flow

• Cash totaled $23.8 million as of September 30, 2025, following the payoff of approximately $17 million of all remaining debt in the third quarter.

Unique Metrics

• The number of active telehealth subscribers increased 14% to approximately 310,000 at quarter-end.

Outlook / Guidance

• For the fourth quarter of 2025, LifeMD expects revenue in the range of $45 million to $46 million and adjusted EBITDA between $3 million and $4 million.
• For the full year 2025, the company anticipates revenue between $192 million and $193 million, reflecting a 24% increase versus 2024, and adjusted EBITDA between $13.5 million and $14.5 million, reflecting a 254% increase versus 2024.